Combigan 0 recalled over manufacturing violations
- Recall date
- March 19, 2019
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Allergan Sales, LLC recalls Combigan (brimonidine tartrate/timolol maleate ophthalmic solution) 0.2%/0.5% 5 mL bottles, Rx only, Allergan, Inc. Irv…
- Recall number
- D-1056-2019
- FDA classification
- Class II
- Brand / firm
- Allergan Sales, LLC
- Sold / distributed
- TN only
Why it was recalled
cGMP Deviations
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Combigan (brimonidine tartrate/timolol maleate ophthalmic solution) 0.2%/0.5% 5 mL bottles, Rx only, Allergan, Inc. Irvine, CA 92612 U.S.A. NDC 0023-9211-05
Get recall alerts
Free email alert whenever Allergan Sales, LLC has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Allergan Sales, LLC